Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 28-Mar-24 6:05 PM View:  | Giraudo Bryan COO/CFO | Gossamer Bio, Inc. (GOSS) | 27-Mar-24 | Sale | 6,430 | $1.16 | $7,430.51 | (1%) 479.18K to 472.75K | |
| 28-Mar-24 6:01 PM View: | Hasnain Faheem President & CEO Director | Gossamer Bio, Inc. (GOSS) | 27-Mar-24 | Sale | 23,172 | $1.16 | $26,772.90 | (< 1%) 5.18M to 5.16M | |
| 28-Mar-24 6:16 PM View: | Christian Waage EVP, Tech Ops and Admin | Gossamer Bio, Inc. (GOSS) | 27-Mar-24 | Sale | 6,430 | $1.16 | $7,429.87 | (< 1%) 660.48K to 654.05K | |
| 19-Mar-24 6:50 PM View: | Peterson Caryn EVP, Regulatory Affairs | Gossamer Bio, Inc. (GOSS) | 18-Mar-24 | Sale | 4,018 | $1.33 | $5,342.73 | (7%) 53.85K to 49.83K | |
| 19-Mar-24 6:50 PM View: | Aranda Richard Chief Medical Officer | Gossamer Bio, Inc. (GOSS) | 18-Mar-24 | Sale | 4,018 | $1.33 | $5,341.93 | (2%) 202.82K to 198.8K | |
| 17-Nov-23 4:01 PM View: | Milligan Sandra Director | Gossamer Bio, Inc. (GOSS) | 15-Nov-23 | Private Purchase | 32,000 | $0.79 | $25,212.80 | 100% 0 to 32.0K | |
| 14-Nov-23 6:24 PM View: | Giraudo Bryan COO/CFO | Gossamer Bio, Inc. (GOSS) | 13-Nov-23 | Private Purchase | 200,000 | $0.56 | $112,880.00 | 72% 279.18K to 479.18K | |
| 26-Jul-23 4:02 PM View: | Hasnain Faheem President & CEO Director | Gossamer Bio, Inc. (GOSS) | 24-Jul-23 | Grant | 540,176 | $1.82 | $983,120.00 | 12% 4.64M to 5.18M | |
| 26-Jul-23 4:03 PM View: | Giraudo Bryan COO/CFO | Gossamer Bio, Inc. (GOSS) | 24-Jul-23 | Grant | 54,020 | $1.82 | $98,316.40 | 28% 196.37K to 250.39K | |
| 26-Jul-23 4:01 PM View: | Christian Waage EVP, Tech Ops and Admin | Gossamer Bio, Inc. (GOSS) | 24-Jul-23 | Grant | 13,504 | $1.82 | $24,577.30 | 2% 637.09K to 650.59K | |
| 26-Jun-23 4:01 PM View: | Aranda Richard Chief Medical Officer | Gossamer Bio, Inc. (GOSS) | 22-Jun-23 | Sale | 1,814 | $1.29 | $2,340.06 | (< 1%) 201.93K to 200.11K | |
| 05-Apr-23 4:26 PM View: | Giraudo Bryan COO/CFO | Gossamer Bio, Inc. (GOSS) | 04-Apr-23 | Private Purchase | 55,000 | $1.02 | $56,094.50 | 32% 170.16K to 225.16K | |
| 22-Mar-23 5:14 PM View: | Hasnain Faheem President & CEO Director | Gossamer Bio, Inc. (GOSS) | 22-Mar-23 | Purchase | 440,500 | $1.14 | $503,580.00 | 10% 4.2M to 4.64M | |
| 22-Mar-23 5:14 PM View: | Hasnain Faheem President & CEO Director | Gossamer Bio, Inc. (GOSS) | 21-Mar-23 | Purchase | 269,389 | $1.20 | $322,324.00 | 7% 3.93M to 4.2M | |
| 22-Mar-23 5:14 PM View: | Hasnain Faheem President & CEO Director | Gossamer Bio, Inc. (GOSS) | 20-Mar-23 | Private Purchase | 168,683 | $1.03 | $174,486.00 | 4% 3.76M to 3.93M | |
| 22-Mar-23 5:19 PM View: | Christian Waage EVP, Tech Ops and Admin | Gossamer Bio, Inc. (GOSS) | 20-Mar-23 | Private Purchase | 18,500 | $1.20 | $22,144.50 | 3% 618.59K to 637.09K | |
| 22-Mar-23 5:17 PM View: | Giraudo Bryan COO/CFO | Gossamer Bio, Inc. (GOSS) | 20-Mar-23 | Private Purchase | 50,000 | $0.97 | $48,435.00 | 42% 120.16K to 170.16K | |
| 20-Mar-23 9:19 AM View: | Peterson Caryn EVP, Regulatory Affairs | Gossamer Bio, Inc. (GOSS) | 16-Mar-23 | Sale | 7,564 | $1.10 | $8,305.27 | (12%) 61.41K to 53.85K | |
| 20-Mar-23 9:22 AM View: | Carter Laura Chief Scientific Officer | Gossamer Bio, Inc. (GOSS) | 16-Mar-23 | Sale | 6,029 | $1.10 | $6,619.84 | (7%) 82.29K to 76.26K | |
| 20-Mar-23 9:21 AM View: | Aranda Richard Chief Medical Officer | Gossamer Bio, Inc. (GOSS) | 16-Mar-23 | Sale | 7,563 | $1.10 | $8,304.17 | (4%) 209.49K to 201.93K | |
| 25-Oct-22 4:57 PM View: | Carter Laura Chief Scientific Officer | Gossamer Bio, Inc. (GOSS) | 24-Oct-22 | Market Sale | 4,876 | $12.07 | $58,867.90 | (6%) 87.17K to 82.29K | (1%) |
| 25-Oct-22 4:55 PM View: | Aranda Richard Chief Medical Officer | Gossamer Bio, Inc. (GOSS) | 24-Oct-22 | Market Sale | 4,757 | $12.07 | $57,431.30 | (2%) 212.73K to 207.97K | (1%) |
| 25-Oct-22 4:59 PM View: | Peterson Caryn EVP, Regulatory Affairs | Gossamer Bio, Inc. (GOSS) | 24-Oct-22 | Market Sale | 4,757 | $12.07 | $57,431.30 | (7%) 66.17K to 61.41K | (1%) |
| 15-Jul-22 4:23 PM View: | Giraudo Bryan COO/CFO | Gossamer Bio, Inc. (GOSS) | 15-Jul-22 | Private Purchase | 13,869 | $7.21 | $99,995.50 | 13% 106.29K to 120.16K | |
| 15-Jul-22 4:27 PM View: | Carter Laura Chief Scientific Officer | Gossamer Bio, Inc. (GOSS) | 15-Jul-22 | Private Purchase | 6,934 | $7.21 | $49,994.10 | 9% 80.23K to 87.17K | |
| 15-Jul-22 4:21 PM View: | Hasnain Faheem President & CEO Director | Gossamer Bio, Inc. (GOSS) | 15-Jul-22 | Private Purchase | 138,696 | $7.21 | $999,998.00 | 4% 3.62M to 3.76M | |
| 15-Jul-22 4:25 PM View: | Christian Waage EVP, Tech Ops and Admin | Gossamer Bio, Inc. (GOSS) | 15-Jul-22 | Private Purchase Duplicate | 6,934 | $7.21 | $49,994.10 | 1% 608.18K to 615.12K | |
| 05-Jul-22 4:39 PM View: | Carter Laura Chief Scientific Officer | Gossamer Bio, Inc. (GOSS) | 01-Jul-22 | Sale | 8,808 | $8.25 | $72,648.40 | (10%) 89.04K to 80.23K | |
| 23-Jun-22 6:47 PM View: | Aranda Richard Chief Medical Officer | Gossamer Bio, Inc. (GOSS) | 22-Jun-22 | Sale | 1,778 | $6.88 | $12,232.60 | (< 1%) 214.21K to 212.44K | |
| 05-May-22 6:14 PM View: | Carter Laura Chief Scientific Officer | Gossamer Bio, Inc. (GOSS) | 04-May-22 | Sale | 1,262 | $7.20 | $9,086.40 | (1%) 90.3K to 89.04K | |
| 24-Mar-22 4:53 PM View: | Giraudo Bryan COO/CFO | Gossamer Bio, Inc. (GOSS) | 23-Mar-22 | Sale | 10,722 | $8.91 | $95,586.60 | (9%) 117.01K to 106.29K | |
| 24-Mar-22 4:55 PM View: | Hasnain Faheem President & CEO Director | Gossamer Bio, Inc. (GOSS) | 23-Mar-22 | Sale | 19,035 | $8.91 | $169,697.00 | (< 1%) 3.64M to 3.62M | |
| 24-Mar-22 4:57 PM View: | Christian Waage EVP, Tech Ops and Admin | Gossamer Bio, Inc. (GOSS) | 23-Mar-22 | Sale | 10,722 | $8.91 | $95,586.60 | (2%) 618.91K to 608.18K | |
| 17-Mar-22 5:00 PM View: | Peterson Caryn EVP, Regulatory Affairs | Gossamer Bio, Inc. (GOSS) | 16-Mar-22 | Sale | 6,279 | $8.28 | $51,977.60 | (9%) 72.45K to 66.17K | |
| 17-Mar-22 5:03 PM View: | Carter Laura Chief Scientific Officer | Gossamer Bio, Inc. (GOSS) | 16-Mar-22 | Sale | 5,002 | $8.28 | $41,406.60 | (5%) 95.31K to 90.3K | |
| 17-Mar-22 4:58 PM View: | Aranda Richard Chief Medical Officer | Gossamer Bio, Inc. (GOSS) | 16-Mar-22 | Sale | 6,278 | $8.28 | $51,975.60 | (3%) 220.49K to 214.21K | |
| 26-Oct-21 5:08 PM View: | Peterson Caryn EVP, Regulatory Affairs | Gossamer Bio, Inc. (GOSS) | 25-Oct-21 | Market Sale | 2,377 | $12.25 | $29,118.20 | (3%) 74.83K to 72.45K | (5%) |
| 26-Oct-21 5:01 PM View: | Carter Laura Chief Scientific Officer | Gossamer Bio, Inc. (GOSS) | 25-Oct-21 | Market Sale | 2,377 | $12.25 | $29,118.20 | (2%) 97.68K to 95.31K | (5%) |
| 26-Oct-21 4:58 PM View: | Aranda Richard Chief Medical Officer | Gossamer Bio, Inc. (GOSS) | 25-Oct-21 | Market Sale | 2,377 | $12.25 | $29,118.20 | (1%) 222.35K to 219.97K | (5%) |
| 01-Jul-21 4:02 PM View: | Carter Laura Chief Scientific Officer | Gossamer Bio, Inc. (GOSS) | 30-Jun-21 | Grant | 25,000 | -- | -- | 34% 72.68K to 97.68K | |
| 22-Jun-21 8:13 PM View: | Aranda Richard Chief Medical Officer | Gossamer Bio, Inc. (GOSS) | 21-Jun-21 | Grant | 15,000 | -- | -- | 7% 204.81K to 219.81K | |
| 05-May-21 5:15 PM View: | Carter Laura Chief Scientific Officer | Gossamer Bio, Inc. (GOSS) | 03-May-21 | Grant | 10,820 | -- | -- | 17% 61.86K to 72.68K | |
| 20-Apr-21 6:07 PM View: | Peterson Caryn EVP, Regulatory Affairs | Gossamer Bio, Inc. (GOSS) | 16-Apr-21 | Grant | 10,820 | -- | -- | 17% 64.01K to 74.83K | |
| 25-Mar-21 4:11 PM View: | Giraudo Bryan Chief Financial Officer | Gossamer Bio, Inc. (GOSS) | 23-Mar-21 | Market Sale | 5,490 | $9.48 | $52,045.70 | (4%) 122.5K to 117.01K | 8% |
| 25-Mar-21 10:00 PM View: | Christian Waage EVP & General Counsel | Gossamer Bio, Inc. (GOSS) | 23-Mar-21 | Market Sale | 5,490 | $9.48 | $52,050.70 | (< 1%) 622.87K to 617.38K | 8% |
| 25-Mar-21 4:13 PM View: | Salter-Cid Luisa Chief Scientific Officer | Gossamer Bio, Inc. (GOSS) | 23-Mar-21 | Market Sale | 5,491 | $9.48 | $52,051.90 | (3%) 211.56K to 206.06K | 8% |
| 01-Mar-21 4:37 PM View: | Christian Waage EVP & General Counsel | Gossamer Bio, Inc. (GOSS) | 25-Feb-21 | Grant | 45,000 | -- | -- | 8% 577.87K to 622.87K | |
| 01-Mar-21 7:40 PM View: | Hasnain Faheem President & CEO Director | Gossamer Bio, Inc. (GOSS) | 25-Feb-21 | Grant | 162,500 | -- | -- | 5% 3.48M to 3.64M | |
| 01-Mar-21 4:54 PM View: | Salter-Cid Luisa Chief Scientific Officer | Gossamer Bio, Inc. (GOSS) | 25-Feb-21 | Grant | 45,000 | -- | -- | 27% 166.56K to 211.56K | |
| 01-Mar-21 4:50 PM View: | Giraudo Bryan Chief Financial Officer | Gossamer Bio, Inc. (GOSS) | 25-Feb-21 | Grant | 45,000 | -- | -- | 58% 77.5K to 122.5K |
